| 摘要 |
<p>Compounds of Formula X: wherein A, X, Y, Z, R5, R6a, and R6b are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegenerative and/or neurological disorders in mammals, including humans.</p> |
| 申请人 |
PFIZER INC. |
发明人 |
CLAFFEY, MICHELLE MARIE;DOUNAY, AMY BETH;GAN, XINMIN;HAYWARD, MATTHEW MERRILL;RONG, SUOBAO;TUTTLE, JAMISON BRYCE;VERHOEST, PATRICK ROBERT |
